Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

NCT04796714 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT04796714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04796714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE
Lead sponsor
University Hospital, Bordeaux
Phase
Phase 4
Overall status
Recruiting
Start date
October 3, 2022
Completion date
May 3, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants, atrial appendage, atrial fibrillation, platelet aggregation inhibitors, stroke